AXSOME THERAPEUTICS, INC. Public Float
AXSOME THERAPEUTICS, INC. (AXSM) had Public Float of $4.40 billion as of 2025-06-30, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-23
- 2025-06-30: Entity Public Float $4.40B.
- 2024-06-30: Entity Public Float $3.20B.
- 2023-06-30: Entity Public Float $2.80B.
- 2022-06-30: Entity Public Float $1.20B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.40B 10-K · filed 2026-02-23 |
| 2024-06-30 | $3.20B 10-K · filed 2025-02-18 |
| 2023-06-30 | $2.80B 10-K · filed 2024-02-23 |
| 2022-06-30 | $1.20B 10-K · filed 2023-02-28 |
| 2021-06-30 | $2.00B 10-K · filed 2022-03-01 |
| 2020-06-30 | $2.40B 10-K · filed 2021-03-01 |
| 2019-06-28 | $675.00M 10-K · filed 2020-03-12 |
| 2018-06-30 | $58.10M 10-K · filed 2019-03-15 |
| 2017-06-30 | $85.50M 10-K · filed 2018-03-07 |
| 2016-06-30 | $83.90M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |